[New pathogenetic and therapeutic aspects of obstructive pulmonary disease].
D000336:Aerosols; D000368:Aged; D000402:Airway Obstruction / Q000150:complications; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001991:Bronchitis / Q000097:blood / Q000188:drug therapy / Q000209:etiology; D001993:Bronchodilator Agents / Q000008:administration & dosage; D002908:Chronic Disease; D005260:Female; D006801:Humans; D011453:Prostaglandins / Q000008:administration & dosage; D011656:Pulmonary Emphysema / Q000097:blood / Q000188:drug therapy / Q000209:etiology; D014361:Trypsin Inhibitors / Q000097:blood
D000336:Aerosols; D000900:Anti-Bacterial Agents; D001993:Bronchodilator Agents; D011453:Prostaglandins; D014361:Trypsin Inhibitors
Neue pathogenetische und therapeutische Aspekte obstruktiver Lungenerkrankungen.